XML 37 R28.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Investments in and Advances to Joint Ventures (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Schedule Of Equity Method Investments [Line Items] |
Summary of Company's Equity Method Joint Ventures Included in Investments in and Advances |
Unconsolidated Real Estate Ventures |  | Partner |  | Effective Ownership Percentage |  | Operating Properties
Dividend Trust Portfolio JV LP |  | Chinese Institutional Investors |  | 20.0% |  | 10
DDRM Joint Venture |  | Madison International Realty |  | 20.0 |  | 2
RVIP IIIB, Deer Park, IL |  | Prudential |  | 25.75 |  | 1
Condensed Combined Financial Information of Company's Unconsolidated Joint Venture Investments | Condensed combined financial information of the Company’s unconsolidated joint venture investments is as follows (in thousands):
| December 31, |
| 2023 |  |  | 2022 |
Condensed Combined Balance Sheets |  |  |  |  |
Land | $ | 180,588 |  |  | $ | 212,326 |
Buildings |  | 558,585 |  |  |  | 643,334 |
Fixtures and tenant improvements |  | 58,626 |  |  |  | 70,636 |
|  | 797,799 |  |  |  | 926,296 |
Less: Accumulated depreciation |  | (187,557 | ) |  |  | (220,642 | )
|  | 610,242 |  |  |  | 705,654 |
Construction in progress and land |  | 1,616 |  |  |  | 1,965 |
Real estate, net |  | 611,858 |  |  |  | 707,619 |
Cash and restricted cash |  | 41,250 |  |  |  | 44,809 |
Receivables, net |  | 9,847 |  |  |  | 11,671 |
Other assets, net |  | 25,498 |  |  |  | 36,272 |
| $ | 688,453 |  |  | $ | 800,371 |
Mortgage debt | $ | 464,255 |  |  | $ | 535,093 |
Notes and accrued interest payable to the Company |  | 2,627 |  |  |  | 2,972 |
Other liabilities |  | 36,279 |  |  |  | 41,588 |
|  | 503,161 |  |  |  | 579,653 |
Accumulated equity |  | 185,292 |  |  |  | 220,718 |
| $ | 688,453 |  |  | $ | 800,371 |
Company's share of accumulated equity | $ | 35,782 |  |  | $ | 42,644 |
Basis differentials |  | 1,099 |  |  |  | (707 | )
Deferred development fees, net of portion related to the Company's interest |  | (136 | ) |  |  | (301 | )
Amounts payable to the Company |  | 2,627 |  |  |  | 2,972 |
Investments in and Advances to Joint Ventures, net | $ | 39,372 |  |  | $ | 44,608 |
Schedule of Fee and Other Income | Revenues earned by the Company related to all of the Company’s unconsolidated joint ventures are as follows (in millions):
| For the Year Ended December 31, |
| 2023 |  |  | 2022 |  |  | 2021 |
Revenue from contracts: |  |  |  |  |  |  |  |
Asset and property management fees | $ | 5.7 |  |  | $ | 7.7 |  |  | $ | 10.6 |
Leasing commissions and development fees |  | 0.4 |  |  |  | 1.9 |  |  |  | 2.2 |
|  | 6.1 |  |  |  | 9.6 |  |  |  | 12.8 |
Other |  | 0.7 |  |  |  | 1.0 |  |  |  | 1.7 |
| $ | 6.8 |  |  | $ | 10.6 |  |  | $ | 14.5 |
Unconsolidated Joint Ventures [Member] |
Schedule Of Equity Method Investments [Line Items] |
Condensed Combined Statements of Operations of Unconsolidated Joint Venture Investments |
| For the Year Ended December 31, |
| 2023 |  |  | 2022 |  |  | 2021 |
Condensed Combined Statements of Operations |  |  |  |  |  |  |  |
Revenues from operations | $ | 92,479 |  |  | $ | 132,494 |  |  | $ | 195,559 |
Expenses from operations: |  |  |  |  |  |  |  |
Operating expenses |  | 23,903 |  |  |  | 35,319 |  |  |  | 53,391 |
Impairment charges |  | — |  |  |  | 17,550 |  |  |  | — |
Depreciation and amortization |  | 32,578 |  |  |  | 46,518 |  |  |  | 66,618 |
Interest expense |  | 25,601 |  |  |  | 34,055 |  |  |  | 43,379 |
Other (income) expense, net |  | 10,467 |  |  |  | 12,303 |  |  |  | 12,074 |
|  | 92,549 |  |  |  | 145,745 |  |  |  | 175,462 |
(Loss) income before gain on disposition of real estate |  | (70 | ) |  |  | (13,251 | ) |  |  | 20,097 |
Gain on disposition of real estate, net |  | 21,316 |  |  |  | 120,097 |  |  |  | 89,935 |
Net income attributable to unconsolidated joint ventures | $ | 21,246 |  |  | $ | 106,846 |  |  | $ | 110,032 |
Company's share of equity in net income of joint ventures | $ | 4,581 |  |  | $ | 22,262 |  |  | $ | 49,417 |
Basis differential adjustments(A) |  | 1,996 |  |  |  | 5,630 |  |  |  | (2,120 | )
Equity in net income of joint ventures | $ | 6,577 |  |  | $ | 27,892 |  |  | $ | 47,297 |
The difference between the Company’s share of net income, as reported above, and the amounts included in the Company’s consolidated statements of operations is attributable to the amortization of basis differentials, the recognition of deferred gains and differences in gain (loss) on sale of certain assets recognized due to the basis differentials.

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph (a) -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph (a) -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=sitc_UnconsolidatedJointVenturesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |